OLR1 and metabolic syndrome: Moreover, increased sLOX-1 and cLDL were significantly associated with the presence of CAD among MetS subjects (OR 4.03; 95% CI: 1.73–11.84, p = 0.019 and OR 11.23; 95% CI: 3.10–40.71, p < 0.001, respectively).